eli lilly news glp-1 is now pharma's top revenue company. It just got FDA approval for an oral GLP-1, but Wall Street isn't celebrating Eli Lilly's $1 Trillion Boom:

Stop use and ask a doctor if: symptoms get worse

An editorial review of Hers vs Brello subscription pricing, clinical oversight, compounded-pharmacy pathway, and the genetic variable neither brand addresses

According to allegations raised in an Ozempic lawsuit filed against Novo Nordisk, side effects of the diabetes drug caused the plaintiffs intestines to fail to contract, resulting in the need for hospitalization and permanent injuries.

2 ,

Hear from Muriel Gonzalez, President of The Vitamin Shoppe, in WWD about how the comprehensive assortment from Whole Health Rx supports a balanced approach to weight management, below or at

A more mindful, wellness-forward approach to GLP-1 use